Article info
PDFCommentary
Treatment-resistant major depressive disorder and assisted dying: response to comments
- Correspondence to Dr Udo Schuklenk, Department of Philosophy, Queens University, Watson Hall, Kingston, Ontario, Canada ON K7L 3N6; udo.schuklenk{at}gmail.com
Citation
Treatment-resistant major depressive disorder and assisted dying: response to comments
Publication history
- Accepted June 17, 2015
- First published July 2, 2015.
Online issue publication
January 03, 2018
Article Versions
- Previous version (3 January 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Other content recommended for you
- Treatment-resistant major depressive disorder and assisted dying
- Choosing death in depression: a commentary on ‘Treatment-resistant major depressive disorder and assisted dying’
- A test for mental capacity to request assisted suicide
- Competence for physician-assisted death of patients with mental disorders: theoretical and practical considerations
- Esketamine for treatment-resistant depression
- New use for an old drug: oral ketamine for treatment-resistant depression
- Why the irremediability requirement is not sufficient to deny psychiatric euthanasia for patients with treatment-resistant depression
- Externalist argument against medical assistance in dying for psychiatric illness
- Drawing the line on physician-assisted death
- Efficacy of repetitive transcranial magnetic stimulation in treatment-resistant depression: the evidence thus far